Related Experiment Video
Updated: Jun 15, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Bacterial deoxyribonucleoside kinases are poor suicide genes in mammalian cells
Claire Hébrard1, Emeline Cros-Perrial, Anders Ranegaard Clausen
1INSERM U590, Laboratoire de Cytologie Analytique, Faculte de Medecine Rockefeller, Universite Claude Bernard Lyon I, Lyon, France.
Abstract:
Transfer of deoxyribonucleoside kinases (dNKs) into cancer cells increases the activity of cytotoxic nucleoside analogues. It has been shown that bacterial dNKs, when introduced into Escherichia coli, sensitize this bacterium toward nucleoside analogues. We studied the possibility of using bacterial dNKs, for example deoxyadenosine kinases (dAKs), to sensitize human cancer cells to gemcitabine. Stable and transient transfections of bacterial dNKs into human cells showed that these were much less active than human and fruitfly dNKs. The fusion of dAK from Bacillus cereus to the green fluorescent protein induced a modest sensitization. Apparently, bacterial dNKs did not get properly expressed or are unstable in the mammalian cell.
Insights
Bacterial deoxyribonucleoside kinases (dNKs) were investigated for sensitizing human cancer cells to gemcitabine. Results showed bacterial dNKs were poorly active in human cells, limiting their therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Deoxyribonucleoside kinases (dNKs) are crucial enzymes in nucleoside metabolism.
- Transferring dNKs into cancer cells can enhance the efficacy of nucleoside analogue drugs.
- Bacterial dNKs have shown potential in sensitizing bacteria to nucleoside analogues.
Purpose of the Study:
- To evaluate the potential of bacterial deoxyadenosine kinases (dAKs) for sensitizing human cancer cells to gemcitabine.
- To assess the expression and activity of bacterial dNKs in mammalian cells.
Main Methods:
- Stable and transient transfection of human cells with bacterial dNK genes.
- Assay of dNK activity in transfected mammalian cells.
- Fusion of Bacillus cereus dAK with green fluorescent protein (GFP).
Main Results:
- Bacterial dNKs exhibited significantly lower activity in human cells compared to human and fruitfly dNKs.
- Fusion of bacterial dAK with GFP resulted in only modest sensitization of cancer cells to gemcitabine.
- Bacterial dNKs appeared to be poorly expressed or unstable in the mammalian cell environment.
Conclusions:
- Bacterial dNKs are not efficiently expressed or are unstable in human cancer cells.
- The limited activity of bacterial dNKs in mammalian cells restricts their use for sensitizing cancer cells to gemcitabine.
- Further research is needed to overcome expression and stability issues for potential therapeutic applications.
More Related Videos
Related Concept Videos
DNA Helicases
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Inhibitors of Bacterial DNA Synthesis
In-vitro Mutagenesis
Fixing Double-strand Breaks
Genome Copying Errors

